BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21925307)

  • 21. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
    Poste G
    Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis.
    Hemmings C
    Pathology; 2010 Feb; 42(2):105-12. PubMed ID: 20085510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status and issues in cancer stem cell study.
    Yang YM; Chang JW
    Cancer Invest; 2008 Aug; 26(7):741-55. PubMed ID: 18608212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cells as a two edged sword--from regeneration to tumor formation.
    Kucia M; Ratajczak MZ
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 7():5-16. PubMed ID: 17228093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer stem cells in solid tumors.
    Er O
    Onkologie; 2009 Oct; 32(10):605-9. PubMed ID: 19816080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stem cells in gastrointestinal cancers: a matter of choice in cell fate determination.
    Wei B; Chen L; Li R; Tian J
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1621-33. PubMed ID: 20942633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cells in the etiology and treatment of cancer.
    Zhang M; Rosen JM
    Curr Opin Genet Dev; 2006 Feb; 16(1):60-4. PubMed ID: 16377171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cancer stem cell concepts--lesson from leukemia].
    Nitta E; Suda T
    Nihon Rinsho; 2009 Oct; 67(10):1863-7. PubMed ID: 19860180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common themes of dedifferentiation in somatic cell reprogramming and cancer.
    Daley GQ
    Cold Spring Harb Symp Quant Biol; 2008; 73():171-4. PubMed ID: 19150965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cells in prostate cancer: treating the root of the problem.
    Taylor RA; Toivanen R; Risbridger GP
    Endocr Relat Cancer; 2010 Dec; 17(4):R273-85. PubMed ID: 20660571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Good cells gone bad: the cellular origins of cancer.
    Wang JC
    Trends Mol Med; 2010 Mar; 16(3):145-51. PubMed ID: 20149745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond tumorigenesis: cancer stem cells in metastasis.
    Li F; Tiede B; Massagué J; Kang Y
    Cell Res; 2007 Jan; 17(1):3-14. PubMed ID: 17179981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer stem cells in solid tumors: an overview.
    O'Brien CA; Kreso A; Dick JE
    Semin Radiat Oncol; 2009 Apr; 19(2):71-7. PubMed ID: 19249644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem cells in solid tumors.
    Ailles LE; Weissman IL
    Curr Opin Biotechnol; 2007 Oct; 18(5):460-6. PubMed ID: 18023337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glioma stem cells: evidence and limitation.
    Fan X; Salford LG; Widegren B
    Semin Cancer Biol; 2007 Jun; 17(3):214-8. PubMed ID: 16750389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.
    Shiras A; Chettiar ST; Shepal V; Rajendran G; Prasad GR; Shastry P
    Stem Cells; 2007 Jun; 25(6):1478-89. PubMed ID: 17332509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells.
    Roorda BD; ter Elst A; Kamps WA; de Bont ES
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):187-98. PubMed ID: 18675551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain tumor stem cells.
    Palm T; Schwamborn JC
    Biol Chem; 2010 Jun; 391(6):607-17. PubMed ID: 20370314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer origin in committed versus stem cells: hypothetical antineoplastic mechanism/s associated with stem cells.
    Torres-Montaner A
    Crit Rev Oncol Hematol; 2011 Nov; 80(2):209-24. PubMed ID: 21420876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-tumor heterogeneity from a cancer stem cell perspective.
    Prasetyanti PR; Medema JP
    Mol Cancer; 2017 Feb; 16(1):41. PubMed ID: 28209166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.